LINE — Lineage, Inc. stock price, charts and financials

QT52Lineage, Inc.

Lineage, Inc. (NASDAQ: LINE) is a Real Estate company in the REIT - Industrial industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
41.35
-1.01-2.38%
OverviewShort InterestFilings
LINEQT52Lineage, Inc.·NASDAQ
41.35-2.38%
News
Down 2.4% — Lineage Cell Therapeutics Q2 Earnings Call Highlights (marketbeat.com).
Medium confidence
TA
Loading chart...
Signal & projected range
Earnings big beat — drift (PEAD)Historical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Premium shows the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands ofhistorical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
CUBE-1.84%$41.00EGP-0.40%$201.94FR-0.94%$63.03REXR-0.80%$36.45TRNO-0.60%$68.35STAG-1.43%$36.77JAN-0.89%$30.20COLD-2.51%$14.59
Snapshot
Index-P/E-EPS (ttm)-0.62Insider Own-Shs Outstand227.67MPerf Week-0.02%
Market Cap9.64BForward P/E-EPS next Y-0.58Insider Trans0.02%Shs Float71.37MPerf Month-3.68%
Enterprise Value17.58BPEG-EPS next Q-Inst Own-Short Float3.09%Perf Quarter5.98%
Income-168.78MP/S1.80EPS this Y-26.46%Inst Trans-Short Ratio6.96Perf Half Y15.30%
Sales5.37BP/B1.22EPS next Y26.40%ROA-0.89%Short Interest7.04MPerf YTD21.03%
Book/sh-P/C8.65EPS next 5Y-ROE-2.07%52W High44.66 -7.41%Perf Year-5.21%
Cash/sh-P/FCF51.03EPS past 3/5Y-ROIC1.56%52W Low30.58 35.21%Perf 3Y-
Dividend Est.2.13 (5.15%)EV/EBITDA12.95Sales past 3/5Y2.81% -Gross Margin10.97%Volatility4.15% 3.31%Perf 5Y-
Dividend TTM2.12 (5.13%)EV/Sales3.27EPS Y/Y TTM83.24%Oper. Margin5.03%ATR (14)1.53Perf 10Y-
Dividend Ex-DateJun 30, 2026Quick Ratio0.70Sales Y/Y TTM0.37%Profit Margin-3.15%RSI (14)49.27Recom2.94
Dividend Gr. 3/5Y-Current Ratio0.78EPS Q/Q-SMA20-0.96%Beta0.99Target Price44.22
Payout-397.04%Debt/Eq1.01Sales Q/Q0.39%SMA50-1.49%Rel Volume1.30Prev Close42.36
Employees24,000LT Debt/Eq0.92EarningsNov 04SMA20010.60%Avg Volume1.04MPrice41.35
IPO DateJul 25, 2024Option/ShortYes / YesEPS/Sales Surpr.21.23% -1.25%Net Debt/EBITDA5.85Volume1,358,120Change-2.38%
Analyst Ratings
DateActionAnalystRatingTarget
Aug-06-26ReiteratedRobert W. Baird$40 → $43
Jul-29-26UpgradeMizuhoNeutral → Outperform$47
Jul-21-26ReiteratedPiper SandlerNeutral$41 → $46
Jul-17-26ReiteratedUBSNeutral$35 → $45
Jun-18-26ReiteratedScotiabankSector Perform$42 → $45
Jun-17-26ReiteratedTruist SecuritiesBuy$40 → $46
Jun-08-26ReiteratedEvercore ISIIn Line$41 → $44
Jun-02-26ReiteratedMorgan StanleyEqual Weight$39 → $47
May-15-26ReiteratedBarclaysUnderweight$34 → $35
May-07-26ReiteratedEvercore ISI GroupIn Line$45 → $41
Latest News
Aug-09-26
Aug-09-2603:04PM
Lineage Cell Therapeutics Q2 Earnings Call Highlightsmarketbeat.com
Aug-06-26
Aug-06-2604:01PM
Lineage Cell Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updatebusinesswire.com
Aug-05-26
Aug-05-2604:30PM
Lineage, Inc. (LINE) Q2 2026 Earnings Call Transcriptseekingalpha.com
01:05PM
Lineage Q2 Earnings Call Highlightsmarketbeat.com
10:31AM
Compared to Estimates, Lineage, Inc. (LINE) Q2 Earnings: A Look at Key Metricszacks.com
08:26AM
Lineage, Inc. (LINE) Beats Q2 FFO and Revenue Estimateszacks.com
06:00AM
Lineage, Inc. Reports Second-Quarter 2026 Financial Resultsbusinesswire.com
Jul-29-26
Jul-29-2604:15PM
PREFORMED LINE PRODUCTS ANNOUNCES RECORD SECOND QUARTER 2026 FINANCIAL RESULTSprnewswire.com
12:48PM
VALUE LINE, INC. ANNOUNCES HIGHER FISCAL YEAR 2026 EARNINGSglobenewswire.com
08:39AM
This CarMax Analyst Is No Longer Bearish; Here Are Top 4 Upgrades For WednesdayBenzinga
Jul-23-26
Jul-23-2607:00AM
Aurora Mobile's GPTBots.ai Enhances Customer Service Solution with Audio Agent and LINE Plugin 2.0globenewswire.com
Jul-21-26
Jul-21-2601:41PM
Piper Sandler Maintains Neutral on Lineage, Raises Price Target to $46Benzinga
Jul-17-26
Jul-17-2604:05PM
VALUE LINE, INC. DECLARES A QUARTERLY CASH DIVIDEND OF $0.35 PER COMMON SHARE AND RENEWS STOCK REPURCHASE PROGRAMglobenewswire.com
08:46AM
UBS Maintains Neutral on Lineage, Raises Price Target to $45Benzinga
Jul-14-26
Jul-14-2603:02AM
Lineage Cell Therapeutics Maps COR1 Path With ‘Thaw and Inject' Cell Therapy Planmarketbeat.com
Company

Lineage, Inc. operates as a real estate investment trust (REIT) primarily focused on temperature-controlled warehouse properties. Its business activities are organized into two main divisions: Global Warehousing and Global Integrated Solutions. The Global Warehousing segment manages a portfolio of industrial real estate assets that provide refrigerated and frozen storage services to its customers. The Global Integrated Solutions segment, in contrast, specializes in delivering tailored cold-chain logistics services. This company was established in 2008 and has its corporate headquarters situated in Novi, Michigan.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
Total Revenue5,3715,3555,340———
Cost of Goods Sold Incl. D&A4,7824,5293,578———
Gross Profit5898261,762———
Selling, General and Administrative Excl. Other556574539———
Research and Development
000———
Other Operating Expense-2370862———
Operating Income270252361———
Interest Expense622268539———
Unusual Expense
——————
Non-Operating Income (Expense)163-99-662———
Net Income Before Taxes-189-115-840———
Income Taxes0-2-89———
Consolidated Net Income-169-98-664———
Net Income From Continuing Operations-189-113-751———
Net Income-169-98-664———
EPS (Recurring)-0.72-0.43-3.70———
EPS (Basic, Before Extraordinaries)-0.72-0.43-3.70———
EPS (Diluted)-0.72-0.43-3.70———
EBITDA1,3571,048547———
Other After Tax Adjustments
——————
Stock Option Compensation Expense
——————
Price To Earnings Ratio
——————
Price To Sales Ratio1.761.492.09———
Gross Margin10.9715.4233.00———
Operating Margin5.034.716.76———
Net Margin-3.15-1.83-12.43———
Shares Outstanding228228191———
Market Capitalization9,4287,98011,187———
Operating Lease Expense
——————
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
$48.46$43.75$39.05$34.34$29.63● Close Price0.00M1.09M2.18M3.28M4.37MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Marchetti Kevin PatrickCo-Executive ChairmanMar 12 '26Buy37.5013,300498,699113,690Mar 16
Marchetti Kevin PatrickCo-Executive ChairmanMar 09 '26Buy39.0511,222438,266100,390Mar 11
Fleming Abigail SChief Accounting OfficerNov 21 '25Buy33.5650016,7835,862Nov 24
LeMasters Robb A.Chief Financial OfficerNov 13 '25Buy33.7430,0001,012,19760,000Nov 17
Forste Adam Matthew SchwartzCo-Executive ChairmanNov 10 '25Buy33.8374,0002,503,250109,266Nov 12
Marchetti Kevin PatrickCo-Executive ChairmanNov 10 '25Buy33.7214,500489,01089,168Nov 12
Crisci RobertChief Financial OfficerNov 07 '25Buy34.5610,000345,630107,859Nov 10
Marchetti Kevin PatrickCo-Executive ChairmanAug 19 '25Buy40.4412,345499,25474,668Aug 20
Thattai Sudarsan VSee RemarksAug 08 '25Buy42.453,563151,2387,983Aug 11
Marchetti Kevin PatrickCO-EXECUTIVE CHAIRMANAug 08 '25Buy42.2823,540995,21562,323Aug 11
Marchetti Kevin PatrickCO-EXECUTIVE CHAIRMANMay 09 '25Buy45.6311,050504,18738,783May 13
Forste Adam Matthew SchwartzCO-EXECUTIVE CHAIRMANMay 08 '25Buy44.9310,949491,92135,266May 12
Marchetti Kevin PatrickCO-EXECUTIVE CHAIRMANMay 06 '25Buy43.7511,500503,07427,733May 07
Thattai Sudarsan VSee RemarksMay 05 '25Buy45.234,420199,9084,420May 07
Forste Adam Matthew SchwartzCO-EXECUTIVE CHAIRMANFeb 28 '25Buy60.5024,3171,471,14424,317Mar 03
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.